Ian A Strohbehn
Overview
Explore the profile of Ian A Strohbehn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Seethapathy R, Zhao S, Long J, Strohbehn I, Sise M
Kidney360
. 2022 Apr;
3(2):269-278.
PMID: 35373125
Background: Remdesivir is not currently approved for patients with eGFR <30 ml/min per 1.73 m. We aimed to determine the safety of remdesivir in patients with kidney failure. Methods: This...
12.
Strohbehn I, Seethapathy R, Lee M, Sise M
Kidney360
. 2022 Apr;
2(8):1316-1325.
PMID: 35369667
Through the discovery of direct-acting antiviral therapies over the last decade, hepatitis C virus (HCV) has been transformed from a highly morbid and potentially fatal chronic viral infection to a...
13.
Sise M, Goldberg D, Schaubel D, Fontana R, Kort J, Alloway R, et al.
Kidney Int Rep
. 2022 Feb;
7(2):241-250.
PMID: 35155863
Introduction: Transplanting kidneys from hepatitis C virus (HCV) viremic donors into HCV-negative patients (HCV D-RNA-positive/R-negative) has evolved from experimental to "standard-of-care" at many centers. Nevertheless, most data derive from single...
14.
Gupta S, Short S, Sise M, Prosek J, Madhavan S, Soler M, et al.
J Immunother Cancer
. 2021 Oct;
9(10).
PMID: 34625513
Background: Immune checkpoint inhibitor-associated acute kidney injury (ICPi-AKI) has emerged as an important toxicity among patients with cancer. Methods: We collected data on 429 patients with ICPi-AKI and 429 control...
15.
Molnar M, Potluri V, Schaubel D, Sise M, Concepcion B, Forbes R, et al.
Am J Transplant
. 2021 Oct;
22(2):599-609.
PMID: 34613666
Kidney transplantation (KT) from deceased donors with hepatitis C virus (HCV) into HCV-negative recipients has become more common. However, the risk of complications such as BK polyomavirus (BKPyV) remains unknown....
16.
Strohbehn I, Street S, Chute D, Seethapathy H, Lee M, Seethapathy R, et al.
Nephrol Dial Transplant
. 2021 Aug;
37(1):187-189.
PMID: 34383953
No abstract available.
17.
Strohbehn I, Zhao S, Seethapathy H, Lee M, Rusibamayila N, Allegretti A, et al.
Kidney Int Rep
. 2021 Jul;
6(10):2565-2574.
PMID: 34307971
Introduction: Acute kidney injury (AKI) is a common complication in patients with severe COVID-19. We sought to compare the AKI incidence and outcomes among patients hospitalized with COVID-19 and with...
18.
Chute D, Zhao S, Strohbehn I, Rusibamayila N, Seethapathy H, Lee M, et al.
Am J Kidney Dis
. 2021 Jun;
79(1):134-137.
PMID: 34174363
No abstract available.
19.
Lee M, Seethapathy H, Strohbehn I, Zhao S, Boland G, Fadden R, et al.
J Immunother Cancer
. 2021 Apr;
9(4).
PMID: 33849926
Background: Current guidelines for treatment of immune checkpoint inhibitor (ICI)-induced nephritis are not evidence based and may lead to excess corticosteroid exposure. We aimed to compare a rapid corticosteroid taper...
20.
Seethapathy H, Lee M, Strohbehn I, Efe O, Rusibamayila N, Chute D, et al.
Nephrol Dial Transplant
. 2020 Dec;
37(3):507-514.
PMID: 33355659
Background: Our objective was to characterize the incidence, risk factors and clinical features of acute kidney injury (AKI) in patients receiving dabrafenib and trametinib. Methods: We performed a retrospective cohort...